keyword
MENU ▼
Read by QxMD icon Read
search

md anderson

keyword
https://www.readbyqxmd.com/read/28089238/ruxolitinib-for-symptom-control-in-patients-with-chronic-lymphocytic-leukaemia-a-single-group-phase-2-trial
#1
Preetesh Jain, Michael Keating, Sarah Renner, Charles Cleeland, Huang Xuelin, Graciela Nogueras Gonzalez, David Harris, Ping Li, Zhiming Liu, Ivo Veletic, Uri Rozovski, Nitin Jain, Phillip Thompson, Prithviraj Bose, Courtney DiNardo, Alessandra Ferrajoli, Susan O'Brien, Jan Burger, William Wierda, Srdan Verstovsek, Hagop Kantarjian, Zeev Estrov
BACKGROUND: Disease-related symptoms impair the quality of life of patients with chronic lymphocytic leukaemia (CLL) who do not require systemic therapy. Available therapies are not specifically aimed at symptom control. Because stimulation of the B-cell receptor activates JAK2 in CLL cells and the JAK2 inhibitor ruxolitinib improves symptoms in patients with myelofibrosis, we postulated that ruxolitinib would improve disease-related symptoms in patients with CLL. We did a phase 2 trial of ruxolitinib to test this hypothesis...
January 11, 2017: Lancet Haematology
https://www.readbyqxmd.com/read/28073578/prophylactic-cranial-irradiation-after-definitive-chemoradiotherapy-for-limited-stage-small-cell-lung-cancer-do-all-patients-benefit
#2
Ahsan S Farooqi, Emma B Holliday, Pamela K Allen, Xiong Wei, James D Cox, Ritsuko Komaki
PURPOSE: Prophylactic cranial irradiation (PCI) can improve overall survival (OS) and suppress brain metastases (BM) in patients with limited-stage small cell lung cancer (LS-SCLC) after complete response to primary therapy. However, PCI can be toxic. We sought to identify characteristics of patients who may not benefit from PCI. METHODS: We identified 658 patients who received chemoradiotherapy at MD Anderson in 1986-2012; 364 received PCI and 294 did not. Median follow-up time was 21...
January 7, 2017: Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology
https://www.readbyqxmd.com/read/28063860/could-objective-tests-be-used-to-measure-fatigue-in-patients-with-advanced-cancer
#3
Gustavo Schvartsman, Minjeong Park, Diane D Liu, Sriram Yennu, Eduardo Bruera, David Hui
CONTEXT: Assessment of cancer-related fatigue is currently based on patient-reported outcomes. We asked whether objective assessments such as muscle strength and nutritional markers can be used as surrogate measures of cancer-related fatigue. OBJECTIVE: We examined the association among three fatigue scales, muscle strength, and nutritional markers in patients with advanced cancer. METHODS: In this prospective study, we enrolled hospitalized cancer patients who had been seen in palliative care consultation at MD Anderson Cancer Center...
January 4, 2017: Journal of Pain and Symptom Management
https://www.readbyqxmd.com/read/28063021/hepatotoxicity-with-vismodegib-an-md-anderson-cancer-center-and-research-on-adverse-drug-events-and-reports-project
#4
Beatrice J Edwards, Dennis W Raisch, Smita S Saraykar, Ming Sun, Josh A Hammel, Hai T Tran, Nathaniel Wehr, Rasha Arabyat, Dennis P West
BACKGROUND: On 30 January 2012, the US FDA approved vismodegib (Erivedge(®), Genentech, CA, USA) for the management of both metastatic and locally advanced basal cell carcinoma. OBJECTIVE: Our objective was to identify evidence of hepatotoxicity with vismodegib in the FDA Adverse Event Reporting System (FAERS) in treated patients in two National Cancer Institute Comprehensive Cancer Centers. METHODS: FAERS was searched for reports dated 1 January 2009 through 31 December 2015 using terms including hedgehog pathway and vismodegib and hepatic-related terms such as liver, jaundice, and hepatitis, among others...
January 6, 2017: Drugs in R&D
https://www.readbyqxmd.com/read/28055120/evaluation-of-proposed-staging-systems-for-human-papillomavirus-related-oropharyngeal-squamous-cell-carcinoma
#5
Ian-James Malm, Caleb J Fan, Linda X Yin, David X Li, Wayne M Koch, Christine G Gourin, Karen T Pitman, Jeremy D Richmon, William H Westra, Hyunseok Kang, Harry Quon, David W Eisele, Carole Fakhry
BACKGROUND: Patients with human papillomavirus (HPV)-related oropharyngeal cancer (OPC) have improved survival when compared with those with HPV-negative OPC. Unfortunately, the American Joint Committee on Cancer seventh edition (AJCC-7ed) staging system does not account for the prognostic advantage observed with HPV-positive OPC. The purpose of the current study was to validate and compare 2 recently proposed staging systems for HPV-positive OPC. METHODS: Patients treated for HPV-positive OPC from 2005 to 2015 at Johns Hopkins Hospital (JHH) were included for analysis...
January 5, 2017: Cancer
https://www.readbyqxmd.com/read/28052061/integrated-genomic-characterization-of-oesophageal-carcinoma
#6
(no author information available yet)
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival rates for these cancers remain dismal. Here we performed a comprehensive molecular analysis of 164 carcinomas of the oesophagus derived from Western and Eastern populations. Beyond known histopathological and epidemiologic distinctions, molecular features differentiated oesophageal squamous cell carcinomas from oesophageal adenocarcinomas. Oesophageal squamous cell carcinomas resembled squamous carcinomas of other organs more than they did oesophageal adenocarcinomas...
January 4, 2017: Nature
https://www.readbyqxmd.com/read/28050927/energy-intake-and-expenditure-of-professional-soccer-players-of-the-english-premier-league-evidence-of-carbohydrate-periodization
#7
Liam Anderson, Patrick Orme, Robert J Naughton, Graeme L Close, Jordan Milsom, David Rydings, Andy O'Boyle, Rocco Di Michele, Julien Louis, Catherine Hambley, John Roger Speakman, Ryland Morgans, Barry Drust, James P Morton
In an attempt to better identify and inform the energy requirements of elite soccer players, we quantified the energy expenditure (EE) of players from the English Premier League (n=6) via the doubly labeled water method (DLW) over a 7-day in-season period. Energy intake (EI) was also assessed using food diaries, supported by the remote food photographic method and 24 h recalls. The 7-day period consisted of 5 training days (TD) and 2 match days (MD). Although mean daily EI (3186 ± 367 kcals) was not different from (P>0...
January 4, 2017: International Journal of Sport Nutrition and Exercise Metabolism
https://www.readbyqxmd.com/read/28048922/mo-de-207b-09-a-consistent-test-for-radiomics-softwares
#8
J Gan, J Wang, H Zhong, R Luo, Z Zhou, P Hu, L Shen, Z Zhang
PURPOSE: The purpose of this study is to investigate the consistency of the features extracted by different radiomics software. METHODS: CT sets of 212 patients with rectum tumor and three existing radiomics feature extraction tools (IBEX from MD_Anderson, RADIOMICS from Maastro, and a MATLAB based code-set from our institution) were enrolled in this study. Among thousands of features that were extracted by three softwares, 273 (between our codes and RADIOMICS), 51 (between IBEX and RADIOMICS) and 34 (between our codes and IBEX) feature pairs were proven to be conjugated according to feature definition...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048906/su-f-t-666-molecular-targeted-gold-nanorods-enhances-the-rbe-of-proton-therapy
#9
A Khoo, N Sahoo, S Krishnan, P Diagaradjane
PURPOSE: In recent years, proton beam radiation therapy (PBRT) has gained significant attention in the treatment of tumors in anatomically complex locations. However, the therapeutic benefit of PBRT is limited by a relative biological effectiveness (RBE) of just 1.1. The purpose of this study is to evaluate whether this limitation can be overcome by artificially enhancing the RBE using molecular-targeted gold nanorods (GNRs). METHODS: Molecular-targeting of GNRs was accomplished using Cetuximab (antibody specific to epidermal growth factor receptor that is over-expressed in tumors) conjugated GNRs (cGNRs) and their binding affinity to Head and Neck cancer cells was confirmed using dark field microscopy and Transmission Electron Microscopy (TEM)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048792/mo-de-206-01-cellular-metabolism-of-fdg
#10
G Pratx
: In this symposium jointly sponsored by the World Molecular Imaging Society (WMIS) and the AAPM, luminary speakers on imaging metabolism will discuss three impactful topics. The first presentation on Cellular Metabolism of FDG will be given by Guillem Pratx (Stanford). This presentation will detail new work on looking at how the most common molecular imaging agent, fluoro-deoxy-glucose is metabolized at a cellular level. This will be followed by a talk on an improved approach to whole-body PET imaging by Simon Cherry (UC Davis)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048613/tu-fg-204-04-an-overview-of-the-ct-protocol-optimization-team-at-md-anderson-cancer-center
#11
D Cody
: The role of a medical physicist involved with clinical CT activities is changing rapidly. No longer is the physicist responsible for simply ensuring scanner QA. This shift is evident by looking at the trend to regulate more and more aspects of what activities must be performed to keep a CT practice within compliance. In this symposium, new guidelines from the ACR, Joint Commission, and several states will be addressed. An overview of these regulations will be provided. Then, three speakers will provide an in-depth account of how their CT protocol Optimization team functions...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048342/we-fg-207b-10-dual-energy-ct-monochromatic-image-consistency-across-vendors-and-platforms
#12
M Jacobsen, C Wood, D Cody
PURPOSE: Although dual-energy CT provides improved sensitivity of HU for certain tissue types at lower simulated energy levels, if these values vary by scanner type they may impact clinical patient management decisions. Each manufacturer has selected a specific dual-energy CT approach (or in one case, three different approaches); understanding HU variability among low monochromatic images may be required when more than one dual-energy CT scanner type is available for use. METHODS: A large elliptical dualenergy quality control phantom (Gammex Inc...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048306/we-fg-bra-04-a-portable-confocal-microscope-to-image-live-cell-damage-response-induced-by-therapeutic-radiation
#13
C McFadden, D Flint, D Sadetaporn, A Asaithamby, D Grosshans, G Sawakuchi
PURPOSE: To construct a custom and portable fluorescence confocal laser-scanning microscope (FCLSM) that can be placed in the path of therapeutic radiation beams to study real-time radiation-induced damage response in live cells. METHODS: We designed and constructed a portable FCLSM with three laser diodes for excitation (405, 488, and 635 nm). An objective lens focuses the excitation light and collects fluorescence from the sample. A pair of galvanometer mirrors scans/collects the laser beam/fluorescence along the focal plane (x/y-directions)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048135/mo-de-206-02-cellular-metabolism-of-fdg
#14
S Cherry
: In this symposium jointly sponsored by the World Molecular Imaging Society (WMIS) and the AAPM, luminary speakers on imaging metabolism will discuss three impactful topics. The first presentation on Cellular Metabolism of FDG will be given by Guillem Pratx (Stanford). This presentation will detail new work on looking at how the most common molecular imaging agent, fluoro-deoxy-glucose is metabolized at a cellular level. This will be followed by a talk on an improved approach to whole-body PET imaging by Simon Cherry (UC Davis)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28047646/su-f-t-606-monte-carlo-evaluation-of-tissue-inhomogeneity-corrections-in-the-treatment-of-liver-cancer-patients-using-stereotactic-body-radiotherapy
#15
D Pokhrel, S Sood, R Badkul, C McClinton, H Jiang, H Saleh, C Lominska
PURPOSE: To evaluate the dosimetric performance of X-ray Voxel Monte Carlo(XVMC) algorithm in effort to clinically validate Monte Carlo-approach in heterogeneous liver phantom and liver SBRT plans. METHODS: An anthropomorphic RPC liver phantom incorporating a liver structure with two cylindrical targets and organs-at-risk (OARs) was used in phantom validation. Subsequently, five patients with metastatic liver cancer were treated using heterogeneity-corrected pencil-beam(PB-hete)algorithm were analyzed following RTOG-1112 criteria ...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28047484/mo-de-206-03-quantifying-metabolism-with-hyperpolarized-mr
#16
J Bankson
: In this symposium jointly sponsored by the World Molecular Imaging Society (WMIS) and the AAPM, luminary speakers on imaging metabolism will discuss three impactful topics. The first presentation on Cellular Metabolism of FDG will be given by Guillem Pratx (Stanford). This presentation will detail new work on looking at how the most common molecular imaging agent, fluoro-deoxy-glucose is metabolized at a cellular level. This will be followed by a talk on an improved approach to whole-body PET imaging by Simon Cherry (UC Davis)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28046922/we-fg-207b-08-dual-energy-ct-iodine-accuracy-across-vendors-and-platforms
#17
M Jacobsen, C Wood, D Cody
PURPOSE: Although a major benefit of dual-energy CT is its quantitative capabilities, it is critical to understand how results vary by scanner manufacturer and/or model before making clinical patient management decisions. Each manufacturer utilizes a specific dual-energy CT approach; cross-calibration may be required for facilities with more than one dual-energy CT scanner type. METHODS: A solid dual-energy quality control phantom (Gammex, Inc.; Appleton, WI) representing a large body cross-section containing three Iodine inserts (2mg/ml, 5mg/ml, 15 mg/ml) was scanned on these CT systems: GE HD-750 (80/140kVp), prototype GE Revolution CT with GSI (80/140kVp), Siemens Flash (80/140kVp and 100/140kVp), and Philips IQon (120kVp and 140kVp)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28046843/su-f-t-665-confocal-microscopy-imaging-of-cell-cycle-distribution-in-cells-treated-with-pegylated-gold-nanoshells
#18
D Sadetaporn, D Flint, C McFadden, A Asaithamby, G Sawakuchi
PURPOSE: To use confocal microscopy to distinguish cells in different phases of the cell cycle before and after treatment with pegylated gold nanoshells (PEG-AuNSs). METHODS: Transfected fibrosarcoma cells (HT1080-EYFP-53BP1-FUCCI) were cultured in T-25 flasks and seeded in glass bottom dishes. These cells express the fluorescent probe AmCyan during the G2/S phases of the cell cycle, mCherry during the G1 phase, and EYFP tagged to the DNA repair protein 53BP1. After allowing cells 4 h to adhere to dishes, PEG-AuNS (Nanospectra Biosciences, Houston, TX) at a concentration of 0...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28046806/su-f-j-144-scatter-and-leakage-survey-of-an-integrated-mr-linac-system
#19
J Wang, G Bosco, B Darenbourg, G Ibbott
PURPOSE: To assess the scatter and leakage radiation of an integrated 1.5T MRI-Linac system. METHODS: A 150cc chamber (model 96020C, Inovision) was used in all the scatter and leakage measurements, after being recalibrated for MV energy by the Accredited Dosimetry Calibration Laboratory at MD Anderson. The scatter radiation was measured by placing a 25 cm stack of solid-water materials at iso-center on the patient couch to simulate patient scatter. Gantry angles were positioned at 0 degree (beam pointing downward) and 270 (beam pointing laterally)...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28046736/mo-de-206-00-joint-aapm-wmis-symposium-metabolic-imaging-of-cancer
#20
John Hazle, Zaver Bhujwalla
: In this symposium jointly sponsored by the World Molecular Imaging Society (WMIS) and the AAPM, luminary speakers on imaging metabolism will discuss three impactful topics. The first presentation on Cellular Metabolism of FDG will be given by Guillem Pratx (Stanford). This presentation will detail new work on looking at how the most common molecular imaging agent, fluoro-deoxy-glucose is metabolized at a cellular level. This will be followed by a talk on an improved approach to whole-body PET imaging by Simon Cherry (UC Davis)...
June 2016: Medical Physics
keyword
keyword
29491
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"